Houlihan Lokey Advises Linden Capital Partners (2)

Houlihan Lokey is pleased to announce that Linden Capital Partners (Linden) has made a majority investment in Vital Care, Inc., alongside current shareholders and management. The transaction closed on October 19, 2020.

Founded in 1986 and headquartered in Meridian, Mississippi, Vital Care is the premier franchisor of home infusion services, with franchises serving a wide range of patients, including those with chronic and acute conditions. The company allows its franchises to provide critical infusion services to patients in a more convenient and lower cost-of-care setting. Vital Care supports more than 50 locally owned franchise locations across 20 states, with a focus on the underserved secondary markets.

Linden is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, the company is one of the country’s largest dedicated healthcare private equity firms. Linden’s strategy is based upon three elements: healthcare specialization, integrated private equity and operating expertise, and its differentiated human capital program. It invests in middle-market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Since its founding, Linden has invested more than $2 billion in healthcare companies and has raised nearly $3 billion of commitments, augmented by capital provided by the firm’s limited partners for larger transactions.

Houlihan Lokey served as the financial advisor to Linden in the Vital Care transaction.

This deal further strengthens Houlihan Lokey’s leadership position in the pharmacy sector. Over the past four years, the firm has closed seven M&A transactions in this space, including three M&A transactions in home and specialty infusion. Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking teams in the country. In 2019, the group was ranked as the No. 1 M&A advisor for all U.S. healthcare transactions under $1 billion by Refinitiv (formerly Thomson Reuters). Houlihan Lokey's Healthcare Group has closed more than 300 M&A healthcare transactions since inception.